Qilian International Corp - נכסים נקיים למניה בודדת QLI

Qilian International (QLI) operates based on the production of antibiotics and traditional remedies, creating a heavy dependence on Chinese regulations. Revenue is generated by veterinary drugs, licorice extracts, and pharmacy sales. This book value per share chart visualizes the capital accumulation vector, where 1.19 characterizes this valuation parameter. Primary threats remain environmental fines, geopolitics, and the unpredictability of the PRC regulator.

Analyzing the historical book value per share of Qilian International (QLI), one can confirm the resilience of the Chinese pharmaceutical and agrochemical manufacturer through asset diversification. This metric reflects the net capital value per share, adjusting under the influence of earnings or share buybacks, which allows an investor to assess the company's internal fundamentals and the protection of investments against market volatility.